Razoxane [21416-67-1]

MedChem Express

Razoxane [21416-67-1]

5

21416-67-1

Research Use Only

99.16

C11H16N4O4

268.27

Razoxane (ICRF 159), a EDTA (HY-Y0682) derivative, is an orally active antiangiogenic topoisomerase II inhibitor. Razoxane has antineoplastic, antiangiogenic, and antimetastatic activities. Razoxanecan be used for the research of renal cell carcinoma (RCC), lung cancer and melanoma cancer[1][2].

CC(CN(CC(N1)=O)CC1=O)N(CC(N2)=O)CC2=O

-20°C

12352200